Orange Book product · Brand (NDA)
LOCAMETZ
GALLIUM GA-68 GOZETOTIDE
At a glance
Mar 23, 2022
Approved
Brand (NDA)
Application
Not listed
TE code
2
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 23, 2022
4 yr 4 mo ago
Today
Patent 11369590 expires
Listed drug substance patent expiration.
Aug 15, 2028
in 2 yr 2 mo
Patent 12109277 expires
Listed method-of-use patent (U-4002) expiration.
Mar 09, 2036
in 9 yr 10 mo
Pharmaceutical detail
Active ingredient
GALLIUM GA-68 GOZETOTIDE
Strength
N/A
Dosage form
POWDER
Route
INTRAVENOUS
TE code
Not listed
Application
NDA 215841
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2025GOZELLIXBrand (NDA)
NDA 219592 · TELIX INNOVATIONS
- 2021ILLUCCIXBrand (NDA)
NDA 214032 · TELIX
- 2020GALLIUM GA 68 GOZETOTIDEBrand (NDA)
NDA 212642 · UNIV CA LOS ANGELES
- 2020GALLIUM GA 68 GOZETOTIDEBrand (NDA)
NDA 212643 · UNIV OF CA SAN FRAN
- 2026GALLIUM GA 68 GOZETOTIDEGeneric (ANDA)
ANDA 216410 · RADIOMEDIX
- 2026GALLIUM GA-68 GOZETOTIDEGeneric (ANDA)
ANDA 219189 · IONETIX
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 11369590 | Aug 15, 2028 | in 2 yr 2 mo | SubstanceProductU-3400 |
| 12109277 | Mar 09, 2036 | in 9 yr 10 mo | U-4002 |

